These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8549825)

  • 1. Inhibition of the catalytic activity of human transaldolase by antibodies and site-directed mutagenesis.
    Banki K; Perl A
    FEBS Lett; 1996 Jan; 378(2):161-5. PubMed ID: 8549825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysine144 is essential for the catalytic activity of Saccharomyces cerevisiae transaldolase.
    Miosga T; Schaaff-Gerstenschlager I; Franken E; Zimmermann FK
    Yeast; 1993 Nov; 9(11):1241-9. PubMed ID: 8109173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Converting Transaldolase into Aldolase through Swapping of the Multifunctional Acid-Base Catalyst: Common and Divergent Catalytic Principles in F6P Aldolase and Transaldolase.
    Sautner V; Friedrich MM; Lehwess-Litzmann A; Tittmann K
    Biochemistry; 2015 Jul; 54(29):4475-86. PubMed ID: 26131847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snapshots of catalysis: the structure of fructose-1,6-(bis)phosphate aldolase covalently bound to the substrate dihydroxyacetone phosphate.
    Choi KH; Shi J; Hopkins CE; Tolan DR; Allen KN
    Biochemistry; 2001 Nov; 40(46):13868-75. PubMed ID: 11705376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transaldolase: from biochemistry to human disease.
    Samland AK; Sprenger GA
    Int J Biochem Cell Biol; 2009 Jul; 41(7):1482-94. PubMed ID: 19401148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of Ser-171 causes inactivation, proteasome-mediated degradation and complete deficiency of human transaldolase.
    Grossman CE; Niland B; Stancato C; Verhoeven NM; Van Der Knaap MS; Jakobs C; Brown LM; Vajda S; Banki K; Perl A
    Biochem J; 2004 Sep; 382(Pt 2):725-31. PubMed ID: 15115436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of Escherichia coli transaldolase into catalytically active monomers: evidence against half-of-the-sites mechanism.
    Schörken U; Jia J; Sahm H; Sprenger GA; Schneider G
    FEBS Lett; 1998 Dec; 441(2):247-50. PubMed ID: 9883893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mode of inhibition by D-tagatose 6-phosphate through a Heyns rearrangement in the active site of transaldolase B variants.
    Stellmacher L; Sandalova T; Schneider S; Schneider G; Sprenger GA; Samland AK
    Acta Crystallogr D Struct Biol; 2016 Apr; 72(Pt 4):467-76. PubMed ID: 27050126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacement of a phenylalanine by a tyrosine in the active site confers fructose-6-phosphate aldolase activity to the transaldolase of Escherichia coli and human origin.
    Schneider S; Sandalova T; Schneider G; Sprenger GA; Samland AK
    J Biol Chem; 2008 Oct; 283(44):30064-72. PubMed ID: 18687684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the reduced Schiff-base intermediate complex of transaldolase B from Escherichia coli: mechanistic implications for class I aldolases.
    Jia J; Schörken U; Lindqvist Y; Sprenger GA; Schneider G
    Protein Sci; 1997 Jan; 6(1):119-24. PubMed ID: 9007983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage of transaldolase by granzyme B causes the loss of enzymatic activity with retention of antigenicity for multiple sclerosis patients.
    Niland B; Miklossy G; Banki K; Biddison WE; Casciola-Rosen L; Rosen A; Martinvalet D; Lieberman J; Perl A
    J Immunol; 2010 Apr; 184(7):4025-32. PubMed ID: 20194725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transaldolase B: trapping of Schiff base intermediate between dihydroxyacetone and epsilon-amino group of active-site lysine residue by borohydride reduction.
    Schneider G; Sprenger GA
    Methods Enzymol; 2002; 354():197-201. PubMed ID: 12418227
    [No Abstract]   [Full Text] [Related]  

  • 13. Conservation of structure and mechanism within the transaldolase enzyme family.
    Samland AK; Baier S; Schürmann M; Inoue T; Huf S; Schneider G; Sprenger GA; Sandalova T
    FEBS J; 2012 Mar; 279(5):766-78. PubMed ID: 22212631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to Bürgi-Dunitz stereochemical principles requires significant structural rearrangements in Schiff-base formation: insights from transaldolase complexes.
    Light SH; Minasov G; Duban ME; Anderson WF
    Acta Crystallogr D Biol Crystallogr; 2014 Feb; 70(Pt 2):544-52. PubMed ID: 24531488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twisted Schiff base intermediates and substrate locale revise transaldolase mechanism.
    Lehwess-Litzmann A; Neumann P; Parthier C; Lüdtke S; Golbik R; Ficner R; Tittmann K
    Nat Chem Biol; 2011 Aug; 7(10):678-84. PubMed ID: 21857661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transaldolase B of Escherichia coli K-12: cloning of its gene, talB, and characterization of the enzyme from recombinant strains.
    Sprenger GA; Schörken U; Sprenger G; Sahm H
    J Bacteriol; 1995 Oct; 177(20):5930-6. PubMed ID: 7592346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human transaldolase gene (TALDO1) is located on chromosome 11 at p15.4-p15.5.
    Banki K; Eddy RL; Shows TB; Halladay DL; Bullrich F; Croce CM; Jurecic V; Baldini A; Perl A
    Genomics; 1997 Oct; 45(1):233-8. PubMed ID: 9339383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transaldolase of Methanocaldococcus jannaschii.
    Soderberg T; Alver RC
    Archaea; 2004 Oct; 1(4):255-62. PubMed ID: 15810435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of catalytically important residues in the active site of Escherichia coli transaldolase.
    Schörken U; Thorell S; Schürmann M; Jia J; Sprenger GA; Schneider G
    Eur J Biochem; 2001 Apr; 268(8):2408-15. PubMed ID: 11298760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redesigning the active site of transaldolase TalB from Escherichia coli: new variants with improved affinity towards nonphosphorylated substrates.
    Schneider S; Gutiérrez M; Sandalova T; Schneider G; Clapés P; Sprenger GA; Samland AK
    Chembiochem; 2010 Mar; 11(5):681-90. PubMed ID: 20148428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.